Interim Chief Executive Officer and Chief Financial Officer · Applied Therapeutics, Inc. (APLT)

Les Funtleyder

FY2024 is the first fiscal year CompBrief holds for Les Funtleyder as a named executive officer of Applied Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,053,846

Salary $530,625Stock awards $153,000Bonus $225,600

4th of 4 named executive officers at Applied Therapeutics by FY2024 total.

4 named officers on file for Applied Therapeutics, FY2024

Les Funtleyder’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Applied Therapeutics’s whole pay program stands against its peers

  • Applied Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on APLT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2025 (DEF 14A).

Free

Get Les Funtleyder’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Les Funtleyder compensation by year

Applied Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Applied Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$530,625
Bonus$225,600
Stock awards$153,000
Option awards$132,000
Non-equity incentive$0
Pension and deferred compensation$0
All other$12,621
Total$1,053,846

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Applied Therapeutics, Inc. DEF 14A filed April 28, 2025, accession 0001193125-25-100674, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Applied Therapeutics, Inc. filed document, accession 0001193125-25-100674. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2025.

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU150,000$129,000—
RSU137,500$118,250—
Option150,000—$1.02

Per the Outstanding Equity Awards at Fiscal Year-End table in Applied Therapeutics, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Applied Therapeutics’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Shoshana ShoshanaShendelman, Ph.D. Former President, Chief Executive Officer and Secretary$3,773,633
John JohnsonExecutive Chairman$2,841,570
Dale HooksChief Commercial Officer$2,059,580
Les Funtleyder · this pageInterim Chief Executive Officer and Chief Financial Officer$1,053,846

The full Applied Therapeutics compensation record

free company brief

This page is one person within Applied Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Applied Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Les Funtleyder's compensation dossier · One-time report. No refunds.